Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

EVOFEM BIOSCIENCES, INC. (EVFM) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

EVOFEM BIOSCIENCES, INC. (EVFM), most recent 12 months reported: revenue $18.05M, net loss $15.28M, free cash flow -$477K. From SEC filings. Others in Pharmaceutical Preparations: SCYNEXIS, Inc. · Celularity Inc. · CytomX Therapeutics, Inc. · uniQure N.V. · Zhengye Biotechnology Holding Limited · EMMAUS LIFE SCIENCES, INC. · Keros Therapeutics, Inc. · Pyxis Oncology, Inc.

Stock screener

Watchlist